ClinVar Miner

Submissions for variant NM_000170.2(GLDC):c.806C>T (p.Thr269Met) (rs386833587)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000049513 SCV000793463 likely pathogenic Non-ketotic hyperglycinemia 2017-08-16 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000049513 SCV000919469 pathogenic Non-ketotic hyperglycinemia 2018-09-28 criteria provided, single submitter clinical testing Variant summary: GLDC c.806C>T (p.Thr269Met) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 246244 control chromosomes. c.806C>T has been reported in the literature in multiple individuals affected with Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) both as a compound heterozygous and homozygous allele (Conter_2006, Coughlin_2017). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on residual enzyme activity, where <10% of normal activity was observed in vitro (Swanson_2015). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Invitae RCV000049513 SCV000945814 pathogenic Non-ketotic hyperglycinemia 2020-10-12 criteria provided, single submitter clinical testing This sequence change replaces threonine with methionine at codon 269 of the GLDC protein (p.Thr269Met). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and methionine. This variant is present in population databases (rs386833587, ExAC 0.02%). This variant has been observed to be homozygous and in combination with another GLDC variant in individuals affected with nonketotic hyperglycinemia (PMID: 16601880, 16450403, 27362913). ClinVar contains an entry for this variant (Variation ID: 56104). This variant has been reported to affect GLDC protein function (PMID: 26179960). For these reasons, this variant has been classified as Pathogenic.
Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) RCV000049513 SCV000081949 probable-pathogenic Non-ketotic hyperglycinemia no assertion criteria provided not provided Converted during submission to Likely pathogenic.
Natera, Inc. RCV000049513 SCV001458165 pathogenic Non-ketotic hyperglycinemia 2020-09-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV001528427 SCV001740165 pathogenic not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV001528427 SCV001808525 likely pathogenic not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV001528427 SCV001928013 pathogenic not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.